Vanguard Group
ZURA icon

Vanguard Group’s Zura Bio ZURA Stock Holding History

Vanguard Group’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.98M Buy
568,118
+50,974
+10% +$202K ﹤0.01% 3434
2025
Q3 		$2.24M Hold
517,144
– – ﹤0.01% 3544
2025
Q2 		$543K Sell
517,144
-325,014
-39% -$389K ﹤0.01% 3901
2025
Q1 		$1.09M Sell
842,158
-37,741
-4% -$59.5K ﹤0.01% 3685
2024
Q4 		$2.2M Buy
879,899
+66,456
+8% +$237K ﹤0.01% 3538
2024
Q3 		$3.3M Buy
813,443
+201,054
+33% +$751K ﹤0.01% 3411
2024
Q2 		$2.14M Buy
612,389
+37,297
+6% +$152K ﹤0.01% 3535
2024
Q1 		$1.48M Buy
575,092
+20,047
+4% +$71K ﹤0.01% 3689
2023
Q4 		$2.59M Buy
555,045
+311,716
+128% +$1.56M ﹤0.01% 3509
2023
Q3 		$1.61M Buy
243,329
+14,977
+7% +$100K ﹤0.01% 3661
2023
Q2 		$1.87M Buy
+228,352
New +$1.83M ﹤0.01% 3682

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group's ZURA Position: Q4 2025 in Review

Vanguard Group increased its Zura Bio (ZURA) stake by 9.9% in Q4 2025, buying an estimated $202K and bringing the position to 568,118 shares worth $2.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

Vanguard Group first reported a position in ZURA in Q2 2023 and has held it in 11 quarters since. The position peaked at $3.3M in Q3 2024. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

  • Vanguard Group held 568,118 shares of Zura Bio worth $2.98M as of Q4 2025.
  • Vanguard Group bought 50,974 Zura Bio shares in Q4 2025, an estimated $202K.
  • Zura Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3434 holding.
  • Vanguard Group first reported a position in Zura Bio in Q2 2023 and has held it in 11 quarters since.
  • Vanguard Group's Zura Bio position peaked at $3.3M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.